The Food and Drug Administration has launched a safety review of two approved RSV drugs for infants, the latest immunizations ...

In a new study, adults 45 and up who got this seasonal virus had a higher risk of major heart issues, especially in the first ...

A new study has found that a significant percentage of adults in the United States have at least one risk factor for severe respiratory syncytial virus (RSV), even as eligibility for the RSV ...

U.S. health regulators informed senior executives at Merck, Sanofi and AstraZeneca last week that their approved protective RSV treatments for infants would face fresh safety scrutiny following ...

The Centers for Disease Control and Prevention have issued a new recommendation to protect babies against RSV. According to the updated guidelines, infants under the age of 8 months should receive a ...

Food and Drug Administration officials have opened a safety review of two injectable drugs used to protect babies and ...

Respiratory virus season is upon the United States as the cold weather months set in, meaning cases of COVID-19, influenza and RSV are set to increase. In its annual outlook report, the Centers for ...

The effectiveness of a single respiratory syncytial virus (RSV) vaccine dose declined among older adults, potentially suggesting the need for booster shots among this demographic. That is according to ...

The season of never-ending sneezing and stuffy noses is underway, sending Americans to pharmacy lines in hopes of keeping illness at bay with yearly shots. While flu and COVID-19 vaccines are an ...